Literature DB >> 15810078

Effects of total glucosides of peony on immunological hepatic fibrosis in rats.

Hua Wang1, Wei Wei, Ni-Ping Wang, Cheng-Yi Wu, Shang-Xue Yan, Li Yue, Ling-Ling Zhang, Shu-Yun Xu.   

Abstract

AIM: To study the effects of total glucosides of peony (TGP) on immunological hepatic fibrosis induced by human albumin in rats.
METHODS: Sixty adult male Sprague-Dawley rats were randomly divided into: Normal group, model group, TGP (60 and 120 mg/kg) treatment groups and colchicines (0.1 mg/kg) treatment group. On the day before the rats were killed, those in TGP or colchicine groups received TGP or colchicine as above from the first day of tail vein injection of human albumin. The rats in normal and model groups were only administered with the same volume of vehicle. At the end of the 16th wk, rats in each group were killed. Blood and tissue specimens were taken. Levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), nitric oxide (NO), content of malondialdehyde (MDA), activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-px), were measured by biochemical methods. Serum procollagen type III (PC III) and laminin (LN) were determined by radioimmunoassay. Liver collagen level was determined by measuring hydroxyproline content in fresh liver samples. Hepatic tissue sections were stained with hematoxylin-eosin and examined under a light microscope.
RESULTS: Histological results showed that TGP improved the human albumin-induced alterations in the liver structure, alleviated lobular necrosis and significantly lowered collagen content. The antifibrotic effect of TGP was also confirmed by decreased serum content of LN and PCIII in TGP-treated group. Moreover, the treatment with TGP effectively reduced the hydroxyproline content in liver homogenates. However, the level of ALT and AST increased in fibrotic rat but had no significance compared with normal control, whereas the ratio of A/G decreased without significance. TGP had no effect on level of ALT, AST and the ratio of A/G. Furthermore, TGP treatment significantly blocked the increase in MDA and NO, associated with a partial elevation in liver total antioxidant capacity including SOD and GSH-px.
CONCLUSION: TGP has beneficial effects on hepatic fibrosis in rats by inhibition of collagen synthesis and decreasing oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15810078      PMCID: PMC4305781          DOI: 10.3748/wjg.v11.i14.2124

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Is liver fibrosis reversible?

Authors:  P A Bonis; S L Friedman; M M Kaplan
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

Review 2.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Oxidative stress: does it 'initiate' hepatic stellate cell activation or only 'perpetuate' the process?

Authors:  Minoti Apte
Journal:  J Gastroenterol Hepatol       Date:  2002-10       Impact factor: 4.029

4.  Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats.

Authors:  I Shimizu; Y R Ma; Y Mizobuchi; F Liu; T Miura; Y Nakai; M Yasuda; M Shiba; T Horie; S Amagaya; N Kawada; H Hori; S Ito
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

Review 5.  Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

Authors:  S L Friedman
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

6.  A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues.

Authors:  I S Jamall; V N Finelli; S S Que Hee
Journal:  Anal Biochem       Date:  1981-03-15       Impact factor: 3.365

7.  Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats.

Authors:  Guangming Lu; Ichiro Shimizu; Xuezhi Cui; Mina Itonaga; Katsuyoshi Tamaki; Hiroshi Fukuno; Hiroshi Inoue; Hirohito Honda; Susumu Ito
Journal:  Life Sci       Date:  2004-01-02       Impact factor: 5.037

Review 8.  Nitric oxide. Biochemistry, pathophysiology, and detection.

Authors:  F L Kiechle; T Malinski
Journal:  Am J Clin Pathol       Date:  1993-11       Impact factor: 2.493

9.  A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies.

Authors:  M Chevallier; S Guerret; P Chossegros; F Gerard; J A Grimaud
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

10.  Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures.

Authors:  V C Gavino; J S Miller; S O Ikharebha; G E Milo; D G Cornwell
Journal:  J Lipid Res       Date:  1981-07       Impact factor: 5.922

View more
  7 in total

1.  Total glucosides of paeony inhibits liver fibrosis and inflammatory response associated with cirrhosis via the FLI1/NLRP3 axis.

Authors:  Jie Zhang; Yiwei Fu; Bin Yang; Xiaoxing Xiang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Antifibrotic effects of ZK14, a novel nitric oxide-donating biphenyldicarboxylate derivative, on rat HSC-T6 cells and CCl4-induced hepatic fibrosis.

Authors:  Li Dai; Hui Ji; Xiang-wen Kong; Yi-hua Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-12-07       Impact factor: 6.150

3.  Paeoniflorin prevents diabetic nephropathy in rats.

Authors:  Jianfang Fu; Yuan Li; Li Wang; Bin Gao; Nanyan Zhang; Qiuhe Ji
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

4.  Protective effects of total glucosides of paeony and the underlying mechanisms in carbon tetrachloride-induced experimental liver injury.

Authors:  Ying Qin; Ya-Ping Tian
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

5.  Comparison of Paeoniflorin and Albiflorin on Human CYP3A4 and CYP2D6.

Authors:  Li-Na Gao; Ye Zhang; Yuan-Lu Cui; Olunga Mary Akinyi
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-19       Impact factor: 2.629

6.  Paeoniflorin mitigates PBC-induced liver fibrosis by repressing NLRP3 formation.

Authors:  Yizhe Zhang; Shujie Zhang; Xin Luo; Han Zhao; Xiaoxing Xiang
Journal:  Acta Cir Bras       Date:  2022-02-18       Impact factor: 1.388

7.  The polysaccharides from Grifola frondosa attenuate CCl4-induced hepatic fibrosis in rats via the TGF-β/Smad signaling pathway.

Authors:  Chao Li; Meng Meng; Mingzhu Guo; Mengyang Wang; Aining Ju; Chunling Wang
Journal:  RSC Adv       Date:  2019-10-21       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.